Inhibition of sodium-glucose cotransporter-2 and liver-related complications in individuals with diabetes: a Mendelian randomization and population-based cohort study.
Sung Won ChungHye-Sung MoonHyunjae ShinHyein HanSehoon ParkHeejin ChoJeayeon ParkMoon Haeng HurMin Kyung ParkSung-Ho WonYun Bin LeeEun-Ju ChoSu Jong YuDong-Ki KimJung Hwan YoonJeong-Hoon LeeYun Joon KimPublished in: Hepatology (Baltimore, Md.) (2024)
Both MRs using 2 European cohorts and a Korean nationwide population-based cohort study suggest that SGLT2 inhibition is associated with a lower risk of liver-related events.